Sydney Lupkin
Stories
-
FDA to raise hurdles for vaccines, faulting COVID shots for 10 kids' deaths
Food and Drug Administration officials say they will ratchet up requirements for vaccine studies, citing concerns about COVID shots for kids. But public health experts question the agency's analysis.
-
Medicare negotiated lower prices for 15 drugs, including 71% off Ozempic and Wegovy
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.
-
5 things to know about the new obesity pills that are on the way
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
-
Obesity drugs, so far only available to take by injection, will soon be in pill form
Pill versions of the obesity drugs now taken only as injections are on the way. We look at the science behind the pills and if they might be more affordable and accessible than the shots.
-
Women experience hair loss too. Here's what can help
Getting a diagnosis is key since there are different causes for the problem calling for different treatments. Here's what to know and how to find support if you are living with hair loss.
-
The FDA will lift warnings on hormone therapy for menopause
Hormone therapy drugs have carried box warning labels for years. The Food and Drug Administration is removing them, saying the risks were overstated.
-
White House strikes new deals to lower prices on obesity drugs for some
The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.
-
White House strikes deals for lower prices on obesity drugs
Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some limitations.
-
Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.
-
AstraZeneca makes deal with White House to lower drug prices
The U.K.-based drugmaker became the second to strike a deal with the Trump administration as part of the president's push to rein in U.S. drug prices.
